Literature DB >> 19180104

Plerixafor.

John F DiPersio, Geoffrey L Uy, Uma Yasothan, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19180104     DOI： 10.1038/nrd2819

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  11 in total

Review 1.  The bicyclam AMD3100 story.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

2.  The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

Authors:  Neal Flomenberg; Steven M Devine; John F Dipersio; Jane L Liesveld; John M McCarty; Scott D Rowley; David H Vesole; Karin Badel; Gary Calandra
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

3.  AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.

Authors:  G Calandra; J McCarty; J McGuirk; G Tricot; S-A Crocker; K Badel; B Grove; A Dye; G Bridger
Journal:  Bone Marrow Transplant       Date:  2007-11-12       Impact factor: 5.483

4.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.

Authors:  Lauri Burroughs; Marco Mielcarek; Marie-Térèse Little; Gary Bridger; Ron Macfarland; Simon Fricker; Jean Labrecque; Brenda M Sandmaier; Rainer Storb
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

5.  Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

Authors:  W Bensinger; F Appelbaum; S Rowley; R Storb; J Sanders; K Lilleby; T Gooley; T Demirer; K Schiffman; C Weaver
Journal:  J Clin Oncol       Date:  1995-10       Impact factor: 44.544

Review 6.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

Review 7.  The use of growth factors in hematopoietic stem cell transplantation.

Authors:  I Pusic; J F DiPersio
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.

Authors:  W Conrad Liles; Hal E Broxmeyer; Elin Rodger; Brent Wood; Kai Hübel; Scott Cooper; Giao Hangoc; Gary J Bridger; Geoffrey W Henson; Gary Calandra; David C Dale
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

9.  Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.

Authors:  Iskra Pusic; Shi Yuan Jiang; Scott Landua; Geoffrey L Uy; Michael P Rettig; Amanda F Cashen; Peter Westervelt; Ravi Vij; Camille N Abboud; Keith E Stockerl-Goldstein; Diane S Sempek; Angela L Smith; John F DiPersio
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

10.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.

Authors:  Hal E Broxmeyer; Christie M Orschell; D Wade Clapp; Giao Hangoc; Scott Cooper; P Artur Plett; W Conrad Liles; Xiaxin Li; Barbara Graham-Evans; Timothy B Campbell; Gary Calandra; Gary Bridger; David C Dale; Edward F Srour
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307
View more
  35 in total

1.  Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.

Authors:  Lauren Veltri; Aaron Cumpston; Alexandra Shillingburg; Sijin Wen; Jin Luo; Sonia Leadmon; Kathy Watkins; Michael Craig; Mehdi Hamadani; Abraham S Kanate
Journal:  Cytotherapy       Date:  2015-10-21       Impact factor: 5.414

2.  CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model.

Authors:  Urszula M Domanska; Jennifer C Boer; Hetty Timmer-Bosscha; Marcel A T M van Vugt; Hilde D Hoving; Nathalie M Kliphuis; Stefano Rosati; Henk G van der Poel; Igle Jan de Jong; Elisabeth G E de Vries; Annemiek M E Walenkamp
Journal:  Clin Exp Metastasis       Date:  2014-08-26       Impact factor: 5.150

3.  Discovery of novel N-aryl piperazine CXCR4 antagonists.

Authors:  Huanyu Zhao; Anthony R Prosser; Dennis C Liotta; Lawrence J Wilson
Journal:  Bioorg Med Chem Lett       Date:  2015-04-17       Impact factor: 2.823

4.  Discovery of N-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties.

Authors:  Yesim A Tahirovic; Valarie M Truax; Robert J Wilson; Edgars Jecs; Huy H Nguyen; Eric J Miller; Michelle B Kim; Katie M Kuo; Tao Wang; Chi S Sum; Mary E Cvijic; Gretchen M Schroeder; Lawrence J Wilson; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2018-04-09       Impact factor: 4.345

Review 5.  Overcoming hurdles in developing successful drugs targeting chemokine receptors.

Authors:  Thomas J Schall; Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2011-04-15       Impact factor: 53.106

Review 6.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

Review 7.  Drug repurposing in oncology--patient and health systems opportunities.

Authors:  Francesco Bertolini; Vikas P Sukhatme; Gauthier Bouche
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

8.  Discovery of tetrahydroisoquinoline-based CXCR4 antagonists.

Authors:  Valarie M Truax; Huanyu Zhao; Brooke M Katzman; Anthony R Prosser; Ana A Alcaraz; Manohar T Saindane; Randy B Howard; Deborah Culver; Richard F Arrendale; Prahbakar R Gruddanti; Taylor J Evers; Michael G Natchus; James P Snyder; Dennis C Liotta; Lawrence J Wilson
Journal:  ACS Med Chem Lett       Date:  2013-09-05       Impact factor: 4.345

9.  Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.

Authors:  Patricia A Cronin; Jiang H Wang; H Paul Redmond
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

Review 10.  Closing the door to human immunodeficiency virus.

Authors:  Yuanxi Kang; Jia Guo; Zhiwei Chen
Journal:  Protein Cell       Date:  2013-03-12       Impact factor: 14.870
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.